Differential	0	12	O
regulation	13	23	O
of	24	26	O
in	27	29	O
vivo	30	34	O
angiogenesis	35	47	O
by	48	50	O
angiotensin	51	62	B-Gene_or_gene_product
II	63	65	I-Gene_or_gene_product
receptors	66	75	I-Gene_or_gene_product
.	75	76	O

Angiotensin	78	89	B-Gene_or_gene_product
II	90	92	I-Gene_or_gene_product
(	93	94	O
ANG	94	97	B-Gene_or_gene_product
II	98	100	I-Gene_or_gene_product
)	100	101	O
,	101	102	O
a	103	104	O
key	105	108	O
regulator	109	118	O
of	119	121	O
blood	122	127	B-Organism_substance
pressure	128	136	O
and	137	140	O
body	141	145	O
fluid	146	151	O
homeostasis	152	163	O
,	163	164	O
exerts	165	171	O
mitogenic	172	181	O
effects	182	189	O
on	190	192	O
endothelial	193	204	B-Cell
cells	205	210	I-Cell
.	210	211	O

We	212	214	O
therefore	215	224	O
hypothesized	225	237	O
that	238	242	O
ANG	243	246	B-Gene_or_gene_product
II	247	249	I-Gene_or_gene_product
could	250	255	O
be	256	258	O
a	259	260	O
mediator	261	269	O
between	270	277	O
homeostatic	278	289	O
changes	290	297	O
within	298	304	O
the	305	308	O
vascular	309	317	B-Multi-tissue_structure
perfusion	318	327	I-Multi-tissue_structure
bed	328	331	I-Multi-tissue_structure
and	332	335	O
growth	336	342	O
factor	343	349	O
-	349	350	O
driven	350	356	O
angiogenesis	357	369	O
.	369	370	O

In	371	373	O
the	374	377	O
present	378	385	O
study	386	391	O
,	391	392	O
we	393	395	O
applied	396	403	O
the	404	407	O
alginate	408	416	B-Drug_or_compound
implant	417	424	O
angiogenesis	425	437	O
model	438	443	O
in	444	446	O
mice	447	451	B-Organism
with	452	456	O
normal	457	463	O
ANG	464	467	B-Gene_or_gene_product
II	468	470	I-Gene_or_gene_product
levels	471	477	O
,	477	478	O
elevated	479	487	O
ANG	488	491	B-Gene_or_gene_product
II	492	494	I-Gene_or_gene_product
levels	495	501	O
by	502	504	O
transgenic	505	515	O
overexpression	516	530	O
of	531	533	O
angiotensinogen	534	549	B-Gene_or_gene_product
(	550	551	O
AOGEN	551	556	B-Gene_or_gene_product
)	556	557	O
,	557	558	O
or	559	561	O
in	562	564	O
AT2	565	568	B-Gene_or_gene_product
receptor	569	577	I-Gene_or_gene_product
-	577	578	O
deficient	578	587	O
mice	588	592	B-Organism
.	592	593	O

We	594	596	O
demonstrate	597	608	O
that	609	613	O
a	614	615	O
decrease	616	624	O
in	625	627	O
the	628	631	O
amount	632	638	O
of	639	641	O
circulating	642	653	O
ANG	654	657	B-Gene_or_gene_product
II	658	660	I-Gene_or_gene_product
by	661	663	O
the	664	667	O
angiotensin	668	679	B-Gene_or_gene_product
-	679	680	I-Gene_or_gene_product
converting	680	690	I-Gene_or_gene_product
enzyme	691	697	I-Gene_or_gene_product
(	698	699	O
ACE	699	702	B-Gene_or_gene_product
)	702	703	O
inhibitor	704	713	O
enalapril	714	723	B-Drug_or_compound
or	724	726	O
the	727	730	O
AT1	731	734	B-Gene_or_gene_product
receptor	735	743	I-Gene_or_gene_product
antagonist	744	754	O
losartan	755	763	B-Drug_or_compound
induced	764	771	O
a	772	773	O
stimulation	774	785	O
of	786	788	O
in	789	791	O
vivo	792	796	O
angiogenesis	797	809	O
implying	810	818	O
an	819	821	O
inhibitory	822	832	O
function	833	841	O
of	842	844	O
ANG	845	848	B-Gene_or_gene_product
II	849	851	I-Gene_or_gene_product
through	852	859	O
the	860	863	O
AT1	864	867	B-Gene_or_gene_product
receptor	868	876	I-Gene_or_gene_product
.	876	877	O

However	878	885	O
,	885	886	O
the	887	890	O
strong	891	897	O
increase	898	906	O
of	907	909	O
angiogenesis	910	922	O
in	923	925	O
AOGEN	926	931	B-Gene_or_gene_product
-	931	932	O
transgenic	932	942	O
mice	943	947	B-Organism
compared	948	956	O
with	957	961	O
mice	962	966	B-Organism
with	967	971	O
normal	972	978	O
ANG	979	982	B-Gene_or_gene_product
II	983	985	I-Gene_or_gene_product
levels	986	992	O
suggests	993	1001	O
additional	1002	1012	O
stimulatory	1013	1024	O
activity	1025	1033	O
.	1033	1034	O

We	1035	1037	O
showed	1038	1044	O
that	1045	1049	O
the	1050	1053	O
ANG	1054	1057	B-Gene_or_gene_product
II	1058	1060	I-Gene_or_gene_product
-	1060	1061	O
induced	1061	1068	O
stimulation	1069	1080	O
of	1081	1083	O
angiogenesis	1084	1096	O
is	1097	1099	O
linked	1100	1106	O
to	1107	1109	O
the	1110	1113	O
AT2	1114	1117	B-Gene_or_gene_product
receptor	1118	1126	I-Gene_or_gene_product
as	1127	1129	O
an	1130	1132	O
impaired	1133	1141	O
induction	1142	1151	O
of	1152	1154	O
angiogenesis	1155	1167	O
was	1168	1171	O
obtained	1172	1180	O
in	1181	1183	O
AT2	1184	1187	B-Gene_or_gene_product
receptor	1188	1196	I-Gene_or_gene_product
knockout	1197	1205	O
mice	1206	1210	O
.	1210	1211	O

These	1212	1217	O
findings	1218	1226	O
provide	1227	1234	O
the	1235	1238	O
first	1239	1244	O
evidence	1245	1253	O
that	1254	1258	O
the	1259	1262	O
AT2	1263	1266	B-Gene_or_gene_product
receptor	1267	1275	I-Gene_or_gene_product
mediates	1276	1284	O
a	1285	1286	O
stimulation	1287	1298	O
of	1299	1301	O
in	1302	1304	O
vivo	1305	1309	O
angiogenesis	1310	1322	O
and	1323	1326	O
indicate	1327	1335	O
that	1336	1340	O
ANG	1341	1344	B-Gene_or_gene_product
II	1345	1347	I-Gene_or_gene_product
is	1348	1350	O
a	1351	1352	O
humoral	1353	1360	O
regulator	1361	1370	O
of	1371	1373	O
peripheral	1374	1384	O
angiogenesis	1385	1397	O
involving	1398	1407	O
two	1408	1411	O
receptor	1412	1420	O
subtypes	1421	1429	O
with	1430	1434	O
opposing	1435	1443	O
actions	1444	1451	O
.	1451	1452	O

